期刊
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
卷 53, 期 47, 页码 12756-12760出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/anie.201406357
关键词
Alzheimer's disease; amyloid beta-peptides; neurotoxicity; oligomers; protein structures
资金
- Swedish Research Council [VR 621-2011-5812]
- Danish National Research Foundation [DNRF59]
- Swedish Alzheimer Foundation [10-03-100, 12-03-119]
- Engineering and Physical Sciences Research Council [EP/F017901/1] Funding Source: researchfish
- EPSRC [EP/F017901/1] Funding Source: UKRI
Oligomeric and protofibrillar aggregates formed by the amyloid-A beta peptide (A beta) are believed to be involved in the pathology of Alzheimer's disease. Central to Alzheimer pathology is also the fact that the longer A beta(42) peptide is more prone to aggregation than the more prevalent A beta(40). Detailed structural studies of A beta oligomers and protofibrils have been impeded by aggregate heterogeneity and instability. We previously engineered a variant of A beta that forms stable protofibrils and here we use solid-state NMR spectroscopy and molecular modeling to derive a structural model of these. NMR data are consistent with packing of residues 16 to 42 of A beta protomers into hexameric barrel-like oligomers within the protofibril. The core of the oligomers consists of all residues of the central and C-terminal hydrophobic regions of A beta, and hairpin loops extend from the core. The model accounts for why A beta(42) forms oligomers and protofibrils more easily than A beta(40).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据